array(3) { ["company_details"]=> array(13) { ["name"]=> string(21) "Cardinal Health, Inc." ["slug"]=> string(28) "cb3e3-us-cardinal-health-inc" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/1120e058-c420-4aa3-8c48-f09983914475" ["description"]=> string(1682) "Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for healthcare facilities. With operations in more than 30 countries and approximately 44,000 employees globally, Cardinal Health is essential to care. We are navigating the complexities of healthcare and providing scaled solutions to help our customers thrive in a changing world. We strive to be a trusted healthcare partner by driving growth in evolving areas of healthcare, while building upon our distribution, products, and solutions to meet customer needs. Disclaimer: LinkedIn is a third-party site unaffiliated with Cardinal Health. Cardinal Health is not responsible for the privacy or security policies or practices on LinkedIn or on any of the third-party websites that we may link to through LinkedIn. You should carefully review the privacy and security practices of LinkedIn and linked third-party websites. We do not necessarily endorse any information found here nor are we responsible for the accuracy of any information, opinions, claims, or advice found here or shared here by our followers. By posting content, ideas, or pictures, you grant Cardinal Health a non-exclusive, royalty-free, perpetual, and worldwide license to use your content and any images posted by you, including the rights to copy, distribute, transmit, display, reproduce, edit, translate, and reformat, and incorporate into a collective work. Cardinal Health reserves all rights relating to the company's LinkedIn account, including removing postings and prohibiting individuals from participating on the page." ["address_street"]=> string(16) "7000 Cardinal Pl" ["address_place"]=> string(6) "Dublin" ["address_region"]=> string(4) "Ohio" ["founding_date"]=> string(10) "1979-02-28" ["website_domain"]=> string(18) "cardinalhealth.com" ["website_url"]=> string(30) "https://www.cardinalhealth.com" ["industry_codes"]=> array(3) { [0]=> string(52) "Medical, Dental, and Hospital Equipment and Supplies" [1]=> string(50) "Drugs, Drug Proprietaries, and Druggists' Sundries" [2]=> string(19) "Management Services" } ["employee_count"]=> int(2800) ["article_count"]=> int(1131) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(55) "Cardinal Health stock target raised on positive outlook" ["snippet_en"]=> string(55) "Cardinal Health stock target raised on positive outlook" ["url"]=> string(112) "https://www.investing.com/news/company-news/cardinal-health-stock-target-raised-on-positive-outlook-93CH-3367688" ["image_url"]=> NULL ["source"]=> string(13) "investing.com" ["publication_date"]=> string(10) "2024-04-05" ["categories"]=> array(3) { [0]=> string(24) "Stock Research & Ratings" [1]=> string(18) "General Investment" [2]=> string(12) "Stock Market" } } [1]=> array(7) { ["title_en"]=> string(44) "5 Dividend Stocks With High Growth Prospects" ["snippet_en"]=> string(139) "Cardinal Health (CAH), Toll Brothers (TOL), Iron Mountain (IRM), NetApp (NTAP) and Ralph Lauren (RL) have strong dividend growth prospects." ["url"]=> string(75) "https://finance.yahoo.com/news/5-dividend-stocks-high-growth-115000570.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/bd46f23f-a7fa-4939-93c6-d2e549b39bc6" ["source"]=> string(9) "yahoo.com" ["publication_date"]=> string(10) "2024-03-08" ["categories"]=> array(2) { [0]=> string(18) "General Investment" [1]=> string(12) "Stock Market" } } [2]=> array(7) { ["title_en"]=> string(82) "MRP Capital Investments LLC Increases Holdings in Cardinal Health, Inc. (NYSE:CAH)" ["snippet_en"]=> string(300) "MRP Capital Investments LLC lifted its position in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 131.5% in the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 31,794 shares of the company's stock after purchasing an additional 18,059 shares during the pe" ["url"]=> string(73) "https://www.marketbeat.com/instant-alerts/nyse-cah-sec-filing-2024-01-19/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/9893ae76-8c0e-4422-932c-a9159444701d" ["source"]=> string(14) "marketbeat.com" ["publication_date"]=> string(10) "2024-01-19" ["categories"]=> array(8) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(5) "R & D" [2]=> string(17) "Academic Research" [3]=> string(24) "Quarterly/Annual Figures" [4]=> string(12) "Stock Market" [5]=> string(25) "Business Model Resilience" [6]=> string(18) "General Investment" [7]=> string(11) "Regulations" } } [3]=> array(7) { ["title_en"]=> string(82) "Cardinal Health, Inc. (NYSE:CAH) Shares Sold by Teacher Retirement System of Texas" ["snippet_en"]=> string(296) "Teacher Retirement System of Texas lessened its position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 11.1% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 225,445 shares of the company's stoc" ["url"]=> string(73) "https://www.marketbeat.com/instant-alerts/nyse-cah-sec-filing-2024-01-18/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/8a180e50-c50f-4f69-b1f5-80bb05f785ba" ["source"]=> string(14) "marketbeat.com" ["publication_date"]=> string(10) "2024-01-18" ["categories"]=> array(8) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(24) "Stock Research & Ratings" [2]=> string(20) "Corporate Governance" [3]=> string(24) "Quarterly/Annual Figures" [4]=> string(16) "Share Repurchase" [5]=> string(12) "Stock Market" [6]=> string(14) "Issuing Shares" [7]=> string(18) "General Investment" } } [4]=> array(7) { ["title_en"]=> string(93) "Bank of New York Mellon Corp Has $195.23 Million Holdings in Cardinal Health, Inc. (NYSE:CAH)" ["snippet_en"]=> string(300) "Bank of New York Mellon Corp reduced its stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 2.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 2,248,712 shares of the company's stock after selling 63,69" ["url"]=> string(73) "https://www.marketbeat.com/instant-alerts/nyse-cah-sec-filing-2024-01-07/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/d25855ce-5f57-435a-a439-d15c24bf3371" ["source"]=> string(14) "marketbeat.com" ["publication_date"]=> string(10) "2024-01-07" ["categories"]=> array(6) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(20) "Corporate Governance" [2]=> string(12) "Stock Market" [3]=> string(18) "General Investment" [4]=> string(11) "Regulations" [5]=> string(11) "Acquisition" } } [5]=> array(7) { ["title_en"]=> string(76) "DAVENPORT & Co LLC Has $317,000 Position in Cardinal Health, Inc. (NYSE:CAH)" ["snippet_en"]=> string(212) "DAVENPORT & Co LLC lowered its stake in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) by 20.4% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission." ["url"]=> string(112) "https://www.defenseworld.net/2024/01/02/davenport-co-llc-has-317000-position-in-cardinal-health-inc-nysecah.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/00ae6a8a-c7bb-41a3-b87f-d3219d354546" ["source"]=> string(16) "defenseworld.net" ["publication_date"]=> string(10) "2024-01-02" ["categories"]=> array(8) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(24) "Stock Research & Ratings" [2]=> string(16) "Share Repurchase" [3]=> string(12) "Stock Market" [4]=> string(14) "Issuing Shares" [5]=> string(18) "General Investment" [6]=> string(11) "Regulations" [7]=> string(9) "Valuation" } } [6]=> array(7) { ["title_en"]=> string(94) "Here's How Much $1000 Invested In Cardinal Health 5 Years Ago Would Be Worth Today By Benzinga" ["snippet_en"]=> string(82) "Here's How Much $1000 Invested In Cardinal Health 5 Years Ago Would Be Worth Today" ["url"]=> string(136) "https://uk.investing.com/news/stock-market-news/heres-how-much-1000-invested-in-cardinal-health-5-years-ago-would-be-worth-today-3283659" ["image_url"]=> NULL ["source"]=> string(13) "investing.com" ["publication_date"]=> string(10) "2024-01-01" ["categories"]=> array(1) { [0]=> string(18) "General Investment" } } [7]=> array(7) { ["title_en"]=> string(53) "Cardinal Health shares lose 0.65 percent (€90.6978)" ["snippet_en"]=> string(141) "Cardinal Health shares are currently trading a little lower on the US stock exchange. Most recently, investors paid $100.30 for the security." ["url"]=> string(91) "https://www.ariva.de/news/cardinal-health-aktie-verliert-0-65-prozent-90-6978-euro-11098679" ["image_url"]=> string(78) "https://images.businessradar.com/articles/ea82950c-8a1a-44db-b66d-e78dac0e4b20" ["source"]=> string(8) "ariva.de" ["publication_date"]=> string(10) "2023-12-28" ["categories"]=> array(7) { [0]=> string(12) "Going Public" [1]=> string(16) "Share Repurchase" [2]=> string(15) "Market Movement" [3]=> string(12) "Stock Market" [4]=> string(14) "Issuing Shares" [5]=> string(18) "General Investment" [6]=> string(9) "Investors" } } [8]=> array(7) { ["title_en"]=> string(63) "Cardinal Health share: price almost constant today (€97.5958)" ["snippet_en"]=> string(166) "Cardinal Health shares are currently unremarkable on the US stock market. The paper last cost $106.68. Little has happened with Cardinal Health's course so far today." ["url"]=> string(131) "https://www.finanznachrichten.de/nachrichten-2023-11/60770445-cardinal-health-aktie-kurs-heute-nahezu-konstant-97-5958-euro-013.htm" ["image_url"]=> string(78) "https://images.businessradar.com/articles/b641559e-3875-4cab-be33-f7e81c687f3c" ["source"]=> string(20) "finanznachrichten.de" ["publication_date"]=> string(10) "2023-11-27" ["categories"]=> array(7) { [0]=> string(24) "Stock Research & Ratings" [1]=> string(21) "Competitive Behaviour" [2]=> string(21) "Shareholders Feedback" [3]=> string(16) "Share Repurchase" [4]=> string(15) "Market Movement" [5]=> string(12) "Stock Market" [6]=> string(18) "General Investment" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(145) } [1]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(116) } [2]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(96) } [3]=> array(2) { ["name"]=> string(16) "Case Settlements" ["count"]=> int(72) } [4]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(53) } [5]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(49) } [6]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(45) } [7]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(43) } [8]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(42) } [9]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(42) } [10]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(39) } [11]=> array(2) { ["name"]=> string(23) "Supply Chain Management" ["count"]=> int(38) } [12]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(35) } [13]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(35) } [14]=> array(2) { ["name"]=> string(24) "Access and affordability" ["count"]=> int(32) } [15]=> array(2) { ["name"]=> string(14) "Product Recall" ["count"]=> int(26) } [16]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(25) } [17]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(25) } [18]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(24) } [19]=> array(2) { ["name"]=> string(23) "Supply Chain Disruption" ["count"]=> int(24) } [20]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(22) } [21]=> array(2) { ["name"]=> string(20) "Corporate Governance" ["count"]=> int(21) } [22]=> array(2) { ["name"]=> string(26) "Product Quality and safety" ["count"]=> int(20) } [23]=> array(2) { ["name"]=> string(12) "Staff hiring" ["count"]=> int(20) } [24]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(20) } [25]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(20) } [26]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(17) } [27]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(16) } [28]=> array(2) { ["name"]=> string(11) "Regulations" ["count"]=> int(14) } [29]=> array(2) { ["name"]=> string(16) "Customer Welfare" ["count"]=> int(13) } } } cb3e3-us-cardinal-health-inc